Evommune, Inc. (EVMN) News
Track canonical SquawkNews coverage tagged to EVMN, Evommune, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
EVMN Initiates Migraine Trial
EVMN starts phase 2b trial
EQUITY | Jul 30, 2026, 12:02 PM UTC
H
Top 3 Health Care Stocks That May Rocket Higher In July
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength o
EARNINGS | Jul 06, 2026, 10:11 AM UTC
L
Morgan Stanley Maintains Overweight on Evommune, Lowers Price Target to $26
Morgan Stanley analyst Judah Frommer maintains Evommune (NYSE: EVMN ) with a Overweight and lowers the price target from $55 to $26.
EQUITY | Jun 30, 2026, 12:56 PM UTC
L
This AAR Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst RJ
EQUITY | Jun 30, 2026, 12:51 PM UTC
H
Crude Oil Gains 2%; Comcast Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The S&P 500 also rose, gai
CENTRAL_BANK | Jun 29, 2026, 04:30 PM UTC